106 related articles for article (PubMed ID: 22260799)
1. Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed mice.
Irwin N; Montgomery IA; Flatt PR
Br J Nutr; 2012 Jul; 108(1):46-56. PubMed ID: 22260799
[TBL] [Abstract][Full Text] [Related]
2. Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
Irwin N; McClean PL; Patterson S; Hunter K; Flatt PR
Biol Chem; 2009 Jan; 390(1):75-80. PubMed ID: 18937625
[TBL] [Abstract][Full Text] [Related]
3. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
Irwin N; Green BD; Parker JC; Gault VA; O'Harte FP; Flatt PR
Regul Pept; 2006 Jul; 135(1-2):45-53. PubMed ID: 16675042
[TBL] [Abstract][Full Text] [Related]
4. Active immunization against (Pro(3))GIP improves metabolic status in high-fat-fed mice.
Montgomery IA; Irwin N; Flatt PR
Diabetes Obes Metab; 2010 Sep; 12(9):744-51. PubMed ID: 20649625
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
Pathak V; Gault VA; Flatt PR; Irwin N
Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
[TBL] [Abstract][Full Text] [Related]
6. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
[TBL] [Abstract][Full Text] [Related]
7. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.
Irwin N; Francis JM; Flatt PR
Biol Chem; 2011 Oct; 392(10):909-18. PubMed ID: 21851286
[TBL] [Abstract][Full Text] [Related]
8. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.
Porter DW; Irwin N; Flatt PR; Hölscher C; Gault VA
Eur J Pharmacol; 2011 Jan; 650(2-3):688-93. PubMed ID: 21050845
[TBL] [Abstract][Full Text] [Related]
9. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.
Porter D; Faivre E; Flatt PR; Hölscher C; Gault VA
Peptides; 2012 May; 35(1):1-8. PubMed ID: 22465882
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide.
Irwin N; Clarke GC; Green BD; Greer B; Harriott P; Gault VA; O'Harte FP; Flatt PR
Biochem Pharmacol; 2006 Sep; 72(6):719-28. PubMed ID: 16859646
[TBL] [Abstract][Full Text] [Related]
11. Alterations of glucose-dependent insulinotropic polypeptide (GIP) during cold acclimation.
Irwin N; Francis JM; Flatt PR
Regul Pept; 2011 Feb; 167(1):91-6. PubMed ID: 21146561
[TBL] [Abstract][Full Text] [Related]
12. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice.
Shimotoyodome A; Suzuki J; Fukuoka D; Tokimitsu I; Hase T
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E652-62. PubMed ID: 20009028
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue.
Ugleholdt R
Dan Med Bull; 2011 Dec; 58(12):B4368. PubMed ID: 22142579
[TBL] [Abstract][Full Text] [Related]
14. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
15. A novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores.
Martin CM; Irwin N; Flatt PR; Gault VA
Biochim Biophys Acta; 2013 Jun; 1830(6):3407-13. PubMed ID: 23518200
[TBL] [Abstract][Full Text] [Related]
16. Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic mice.
Bailey CJ; Flatt PR; Kwasowski P; Adams M
Diabete Metab; 1986 Dec; 12(6):351-4. PubMed ID: 3545933
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
Irwin N; McClean PL; Hunter K; Flatt PR
Diabetes Obes Metab; 2009 Jun; 11(6):603-10. PubMed ID: 19515180
[TBL] [Abstract][Full Text] [Related]
18. Role of the gut Peptide glucose-induced insulinomimetic Peptide in energy balance.
Pfeiffer AF; Rudovich N; Weickert MO; Isken F
Results Probl Cell Differ; 2010; 52():183-8. PubMed ID: 20865381
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects.
Brøns C; Jacobsen S; Hiscock N; White A; Nilsson E; Dunger D; Astrup A; Quistorff B; Vaag A
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E43-51. PubMed ID: 21917634
[TBL] [Abstract][Full Text] [Related]
20. An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice.
Hasib A; Ng MT; Gault VA; Khan D; Parthsarathy V; Flatt PR; Irwin N
Diabetologia; 2017 Mar; 60(3):541-552. PubMed ID: 28004148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
